BNGO
What one share of Bionano Genomics holds
Laboratory Analytical Instruments
We are a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Our mission is to transform the way the world sees the genome through optical genome mapping (“OGM”) solutions, nucleic acid extraction and purification systems, diagnostic services and software.
Bionano Genomics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.16 |
|---|---|
| Profit | −$3.37 |
| Cash and investments | $0.32 |
| Book value | $2.68 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $35.19 | −$86.50 | $3.77 | −$80.84 | — | — |
| 2018 | $16.96 | −$26.14 | $0.47 | −$28.65 | — | $10.08 |
| 2019 | $6.76 | −$19.91 | $0.04 | −$19.76 | — | — |
| 2020 | $0.82 | −$3.94 | $0.00 | −$3.68 | — | $1.85 |
| 2021 | $0.65 | −$2.62 | — | −$2.60 | — | $11.64 |
| 2022 | $0.96 | −$4.58 | — | −$4.32 | — | $8.39 |
| 2023 | $63.47 | −$408.60 | — | −$220.00 | — | $126.10 |
| 2024 | $24.21 | −$88.13 | — | −$54.23 | — | $18.96 |
| 2025 | $5.24 | −$4.85 | — | −$3.00 | — | $4.14 |